We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clostridium difficile infection: new insights into management.
- Authors
Khanna, Sahil; Pardi, Darrell S
- Abstract
Clostridium difficile was first described as a cause of diarrhea in 1978 and is now among the leading 3 hospital-acquired infections in the United States, along with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. In the past 2 decades, there has been an increase in the incidence, severity, and recurrence rates of C difficile infection, all of which are associated with poor outcomes. In addition, several novel risk factors and newer treatment methods are emerging, including fidaxomicin therapy, treatment using monoclonal antibodies, and fecal microbiota transplantation, that have shown promise for the treatment of C difficile infection. This review focuses on the changing epidemiology, risk factors, and newer methods for treatment of C difficile infection.
- Publication
Mayo Clinic proceedings, 2012, Vol 87, Issue 11, p1106
- ISSN
1942-5546
- Publication type
Journal Article
- DOI
10.1016/j.mayocp.2012.07.016